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Breastfeeding, especially exclusive breastfeeding in the first months of life, is the cornerstone of 
good infant nutrition, health and survival. The various health benefits include the mother and 
also extend beyond infancy to protection against common noncommunicable diseases in adult 
life. These benefits take on even greater salience in low-resource settings.
Mother-to-child transmission (MTCT) of HIV through breastfeeding and the Centers for Disease 
Control’s initial recommendation that HIV-infected women avoid breastfeeding their infants, 
threatened this key child health-promoting activity. Support for breastfeeding by HIV-infected 
women is steadily being reinstated, however. This change was prompted by numerous reports 
that formula feeding incurred significant harm1 and was also facilitated by a 1999 report that 
showed significantly reduced postnatal HIV transmission if breastfeeding was exclusive.2 
Further impetus came from a demonstration that postnatal transmission is almost eliminated 
if maternal combination antiretroviral treatment (cART) or extended infant antiretroviral peri-
exposure prophylaxis (PEEP) is provided during breastfeeding.3 In 2012, even the British HIV 
Association (BHIVA) guidelines permitted breastfeeding under tightly controlled circumstances, 
if mothers insisted.
The 2010 South African Prevention of Mother-To-Child HIV Transmission (PMTCT) Guidelines 
incorporated this evidence and were broadly supportive of HIV-infected women breastfeeding 
their infants, but stopped short of adopting breastfeeding as the programme’s default feeding 
choice. The Tshwane Declaration in August 2011 shifted South Africa squarely onto the 
breastfeeding restoration path. Besides promoting, protecting and supporting breastfeeding 
generally, the declaration specifically adopts breastfeeding as the default feeding method for 
HIV-exposed infants and promotes human milk banks to support breastfeeding and breast milk 
feeding. The Tshwane Declaration was followed by the promulgation of regulations (R991/2012) 
to enforce the international code on marketing of breast milk substitutes. Nevertheless, South 
Africa still lags behind many other African countries in the uptake and duration of breastfeeding 
and the duration of exclusive breastfeeding.4
New guidelines to improve PMTCT in South Africa have recently been released and recommend 
lifelong cART for all pregnant women and those who have delivered in the preceding 12 months, 
irrespective of disease and laboratory criteria.
Four important new dimensions provide greater attention to neonates, namely (1) birth 
polymerase chain reaction (PCR) testing of high-risk neonates, (2) extended infant antiretroviral 
(ARV) prophylaxis if early breastfeeding risk is increased owing to inadequate duration of maternal 
cART, (3) combination infant ARV prophylaxis (cARP) if intrapartum transmission risk is increased 
and (4) very early initiation of cART in infected neonates. In the present article, we discuss the 
implications of these new programme and policy developments for breastfeeding.
The first issue is the specific counselling needs of women whose infants are HIV-infected. The 
new birth PCR testing programmes will identify most HIV-infected infants much earlier than 
the old 6-weeks PCR testing programmes.5 This approach provides a valuable opportunity for 
strengthening support for breastfeeding, which is essential to the survival and well-being of HIV-
infected infants. HIV-infected infants should be breastfed for 2 years or more.
Secondly, by design, the new, targeted birth testing programmes will encompass a large 
proportion of preterm and low birthweight (LBW) neonates. Many challenges exist to maintain 
optimal breastfeeding and clinical care for this high-risk group, regardless of HIV exposure status. 
HIV clinicians will need to improve their skills and expertise in this area as caring for more of 
these vulnerable infants becomes their responsibility. In turn, neonatologists and paediatricians 
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Thirdly, risk estimation linked to targeted testing or 
augmented infant prophylaxis will identify women with 
suboptimal cART, including those who have not yet 
accessed care, those who deliberately avoided care, those 
who are non-adherent, those who are failing cART, late 
starters, etc. Counselling around infant feeding for this 
group will need to balance HIV transmission risks against 
the adverse and potentially fatal outcomes associated with 
abstinence from breastfeeding, particularly in preterm and 
LBW infants.
HIV-infected neonates
Infant feeding counselling in PMTCT programmes has 
mostly ignored the scenario of known HIV-infected neonates. 
Typically, counselling has been directed at HIV-infected 
women with infants of unknown HIV status. Whilst antenatal 
counselling still has to keep this focus, postnatal counselling 
will now have the benefit of much earlier diagnosis of HIV 
infection than was previously possible. If a sample for a 
PCR test is collected at birth, the mother should be able to 
learn her infant’s HIV status in a matter of days, depending 
on the turnaround time of the laboratory and the schedule 
of follow-up visits. This time could be reduced to a few 
hours if point-of-care (POC) tests are used routinely in the 
clinical setting. For an infant diagnosed as infected, earlier 
diagnosis offers a valuable opportunity for strengthening 
support for breastfeeding. Breastfeeding is crucial for the 
wellbeing of HIV-infected infants who are at exceedingly 
high risk of mortality.6 Breastfeeding for two years or more 
can be unequivocally recommended and supported for the 
infected infant, as the risk of HIV transmission is no longer a 
consideration.
However, learning the infant’s diagnosis is challenging for 
mothers. Many are distressed and experience feelings of 
guilt. They should be reassured that any ’re-infection’, should 
it even occur, will not accelerate disease progression in their 
infant and that the protective benefits of breastfeeding in an 
HIV-infected child far outweigh the minuscule possibility of 
harm.
Very early diagnosis also provides a window of opportunity 
to begin or restart breastfeeding for those who either 
decided to forgo all breastfeeding or who stopped before the 
infant’s diagnosis. Healthcare workers and the community 
are often quite ignorant of the reversible nature of infant 
feeding decisions. An innovative programme in Soweto 
demonstrated that a modest relactation counselling program 
had reasonable success in achieving full lactation after infant 
HIV diagnosis, even in mothers who had abstained entirely 
from breastfeeding until infant diagnosis around 12 weeks 
of age.7
Preterm and low birthweight 
neonates
Preterm and LBW infants are generally at higher risk of 
perinatal HIV transmission than term, normal birthweight 
infants. They also may have biological reasons for increased 
susceptibility to enteral acquisition of HIV from breast 
milk. In addition, preterm birth before adequate passive 
transfer of maternal neutralising antibodies may cause 
reduced protection against postnatal HIV infection. This is 
why preterm birth and/or LBW is included as one of the 
criteria for targeted birth testing and, in the Western Cape, 
for cARP.
Few studies of extended infant prophylaxis include 
preterm infants, despite their higher risk of infection, and 
special dosage considerations are required in this group.8 
Nevertheless, combining infant PEEP with maternal cART is 
advisable in this group, as avoidance of breastmilk feeding 
increases morbidity and mortality significantly.
The immature, preterm gut is nowhere near as robust 
as the term gut with, initially, relative hypomotility, 
underdeveloped microvilli and brush border enzymes 
predisposing to malabsorption, stasis, bacterial overgrowth 
and inflammation, particularly if fed injudiciously. Very 
gentle graduated feeding with human milk reduces the 
risk of intestinal inflammation and necrotising enterocolitis 
(NEC). NEC is three times more common with formula milk 
than with donated human milk feeding.9 Gut inflammation is 
likely to increase the number of CD4 cells and CCR5 receptor 
expression and increase vulnerability to HIV transmission. 
Additionally, HIV-exposed infants may be more at risk of 
developing NEC, worse grades of progressive NEC and 
mortality from NEC with worse outcomes after surgery.10
Consequently, whilst human milk feeding is critical to better 
outcomes in HIV-exposed preterm neonates, it may involve 
the risk of HIV transmission despite ARV prophylaxis. It may 
be advisable to complement infant PEEP and maternal cART 
to further reduce transmission risk. Consideration should be 
given to heat treatment of the infant’s own mother’s milk or 
feeding with human milk from an HIV-negative donor at least 
temporarily whilst feeds are being established and preterm 
gut matures in the first few weeks of life. Over-reliance on 
donated human milk should be discouraged, as this does not 
facilitate sustained breastfeeding after discharge whilst heat 
treatment of own mother’s milk does.
Human milk banks have a critical role in supporting 
breastmilk feeding, and the South African Department of 
Health is currently developing regulations on milk banking. 
Some provinces and non-governmental organisation 
(NGOs) have already developed milk banks and milk bank 
networks.
One of the postulated mechanisms for the increased rate 
of transmission in mixed breastfeeding infants is that 
cow’s milk protein or solid food causes low-grade gut 
inflammation, thus increasing susceptibility. This possibility 
may be especially true for the immature gut. Preservation 
of exclusive breastmilk feeding may be facilitated by the 
temporary use of donated human milk until lactation is fully 
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established or the next batch of own mother’s milk is brought 
from home.
There are some data to suggest that heat treatment of 
expressed breast milk (EBM) at home may be implementable 
but this complicated approach requires a great deal of 
motivation from family and adequate support from the 
health service. The approach is worth considering in preterm 
neonates in hospital with additional risk factors such as 
mothers who fail therapy or who are drug resistant. The bulk 
of feeds would initially be by gastric tube, and this facilitates 
heat treatment of EBM. Cup feeding of heat-treated EBM 
may also be considered. It is probably safe to transition to 
suckling directly from the breast with extended infant ARP 
and maternal cART cover once the gut has matured and full 
enteral feeds are established and well tolerated. Minimally 
nutritive suckling may accelerate oro-motor maturation and 
should be encouraged.
Sustaining lactation in mothers of preterm infants can be 
challenging, particularly when faced with meagre lodging 
facilities, prolonged maternal-infant separation especially 
because of severe maternal illness, infrequent visiting owing 
to poverty or substance abuse, and inadequate support for 
sibling care especially in recently migrated impoverished 
families. In addition, postnatal depression and poor 
advice from healthcare workers may undermine sustained 
breastfeeding. Mothers should be informed that fortification 
of their milk to meet the increased nutrient demands of the 
preterm infant is preferable to special preterm formula. 
Whilst some infrastructure issues may be dealt with at a 
health systems level, commitment to the Mother and Baby 
Friendly Initiative (MBFI) principles, Kangaroo Infant Care 
and promotion of routine early and regular emptying of 
breasts by manual and mechanical expression are vital 
to support and sustain breastfeeding. Pharmacological 
interventions to optimise milk expression may also be helpful 
but, by and large, the most important component is parental 
education and ‘buy-in’ of the benefits of breastfeeding. 
An institutionalised belief that breastfeeding is a critical 
component of preterm care goes a long way to reverse the 
tendency to rely on formula milk as a short-term, quick-fix 
option.
This complex subset of preterm and LBW infants neonates 
poses many challenges for ensuring optimal and sustained 
breastfeeding and care whilst preventing HIV infection. 
HIV clinicians, neonatologists and paediatricians will have 
to rise to this challenge as these babies become the focus of 
intensified risk-based prophylaxis and, if infected, cART in 
the first weeks of life.
Some hospitals have sophisticated programmes to help 
support breastfeeding of preterm infants including kangaroo 
infant care, heat-treatment stations and active milk banks. 
Other hospitals, however, need to establish this capacity as 
soon as possible.
Neonates of mothers who are  
non-adherent or have drug-resistant 
virus
Infants whose mothers have had suboptimal ARV exposures 
will constitute the majority of high-risk infants identified for 
targeted testing or cARP. This group includes women who 
have only recently learned their HIV status; those who have 
deliberately absented themselves from programmes, are 
non-adherent or defaulters and those not yet able to access 
appropriate services. All of these characteristics point to 
challenging social circumstances. Ensuring that the mothers 
of these high-risk infants obtain HIV-related care and ARVs 
necessary for their own health is as important as ensuring the 
best available prophylaxis for their infants.
Given the probable social disadvantage of women who are 
partially adherent to cART, the new advice that women who 
are failing second- or third-line treatment should formula 
feed is, in most circumstances, ill-advised. There are no 
special reasons to avoid breastfeeding in this group. The 
same risk/benefit considerations for breastfeeding in all 
HIV-exposed infants apply to this subgroup, and many will 
have social circumstances that could amplify the adverse 
consequences of avoiding breastfeeding.
Invoking risk of transmission of drug-resistant virus through 
breastfeeding as the motivation for avoiding it is not logical. 
Concerns about transmission of drug resistance in this 
situation are overstated and confused. Almost all infants who 
fail PMTCT (i.e. become infected despite being exposed to 
ARVs) have virus resistance to a number of first-line ARVs.11 
The paediatric treatment guidelines already address this by 
recommending initiation with ritonavir-boosted lopinavir 
(LPV/r)-based cART for HIV-infected infants from 42 weeks’ 
corrected gestational age and young children under 3 years 
of age. MTCT of resistance to LPV/r is exceedingly rare. We 
are aware of one report of transmitted LPV/r resistance to 
an infant via perinatal rather than postnatal transmission.12 
Trials using LPV/r for PMTCT have not observed frequent 
emergence of LPV/r resistance in either mothers or infants.13 
Even if it were to occur, the small risk of resistance applies 
only to the small population of infants who are infected. 
Avoiding breastfeeding for the benefit of a tiny minority 
places the majority of HIV-exposed uninfected infants at risk 
of poor health and development.
Fear of HIV transmission during breastfeeding looms large, 
and fear of transmission of drug-resistant HIV even larger. 
This fear seems to blind providers to the immediate risks of 
poor growth, pneumonia and diarrhoea, significantly more 
likely to be worse or fatal in the non-breastfed infant.1 The 
risks of postnatal HIV transmission are almost 20 times 
less than during the pregnancy and delivery. ARVs given 
to the mother or to the infant reduce risks via all of these 
routes by a factor of more than 10 (Figure 1). In the event of 
suboptimal adherence to ARVs, the risk of HIV transmission 
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does not exceed that observed in the absence of ARVs. Risks 
of transmission in this partially adherent group will be less 
than the risks when no ARVs are given.
The social circumstances and health service access issues 
associated with this subgroup tend to exacerbate the 
adverse effects of abstinence from breastfeeding. Formula 
feeding should only be considered in this group if all 
options of ensuring access to ARVs for mother and infant 
have been exhausted or there are absolutely no prospects of 
breastfeeding because serious maternal substance addiction 
will grossly interfere with it.
Conclusion
Risk recognition linked to improved testing and infant 
prophylaxis may further reduce transmission, diagnose 
infection earlier and improve linkage to definitive care and 
treatment. There is a danger that when transmission risk is 
increased, replacement feeding may be considered to prevent 
postnatal transmission despite breastfeeding being critical 
to infant health and survival. The few paediatric infections 
averted will be at the expense of harm to the majority who 
are HIV-exposed but uninfected.
Even with imperfect prophylaxis, less than 1% of infants 
become infected in each month of breastfeeding. Promoting 
replacement feeding denies breastfeeding benefits to the more 
than 99% of HIV-exposed infants who remain uninfected. 
Importantly, these benefits would also be denied to the high-
risk infants infected during birth and only diagnosed at 6 
weeks of age or older. Clinicians may struggle to keep this in 
mind when counselling the individual ’high-risk’ patient on 
feeding choices, and should avoid inflating the real but tiny 
risk of transmission and understating the real harm from not 
breastfeeding.
At a public health level, occasional individual infections 
via breastfeeding are a small price to pay for a compelling 
benefit to the majority. The low frequency of transmission 
IU, intrauterine; IP, intrapartum; BF, breastfeeding; m, months; ARVs, antiretrovirals.
FIGURE 1: Risks of HIV transmission with (in red) and without (in purple) 
antiretroviral drugs occurring during the intrauterine, intrapartum and during 
months 1–9 via breastfeeding. The risks of transmission amongst mothers who 
are non-adherent, failing therapy or drug resistant are likely to lie between these 
two estimates.
























during breastfeeding, even when risk is increased, allows 
time to optimise maternal cART to reduce risk rather than 
promoting formula feeding.
A weak point in the old early infant diagnosis programme 
was a tendency towards early termination of breastfeeding 
around 10–12 weeks when receiving the negative result 
from the 6-weeks test. This pattern suggested a missed 
opportunity to support breastfeeding at this critical juncture. 
It is unclear whether counselling specifically encouraged 
women to stop breastfeeding or whether messaging around 
the need for retesting inadvertently failed to convey the 
importance of continued breastfeeding. Vigilance is needed 
when counselling mothers about the meaning of negative 
birth PCR tests to ensure that this counselling does not 
inadvertently discourage breastfeeding.
Breastfeeding and breastmilk feeding remain the best feeding 
method to optimise health outcomes in PMTCT, even when 
mothers are failing first- and second-line treatment. The 
counselling messages after birth testing must include clear 
support for breastfeeding if we are to leverage the full 
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